Sort
30,917 grants matching “tumor microenvironment”
Breast Cancer Intravoxel-incoherent-motion MRI Multisite (BRIMM) Study - Resubmission - 1
$395,274Eric Edward Sigmund · New York University School Of Medicine · UG3 · FY2021 · CA
Cellular crosstalk in the hematopoietic microenvironment
$395,270Daniel Lucas · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
$395,166Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
$395,166Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
$395,166Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Therapeutically Targeting Plasmacytoid Dendritic Cells in Multiple Myeloma
$395,166Kenneth C Anderson · Dana-Farber Cancer Inst · R01 · FY2018 · CA
IRE1/XBP1s signaling: a novel essential regulator for bone marrow microenvironmen
$395,164Hongjiao Ouyang · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · CA
Amoeboid Membrane Dynamics in Prostate Cancer
$395,145Michael R Freeman · Boston Children'S Hospital · R01 · FY2011 · CA
Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma
$395,129Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · CA
Targeting Plasmacytoid Dendritic Cells to Treat Human Myeloma
$395,129Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$395,126Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2021 · CA
Cellular Immunotherapy of Ovarian Cancer
$395,109Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Cellular Immunotherapy of Ovarian Cancer
$395,109Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Enhancing Viral Oncolysis with Vasculostatin Gene Delivery
$395,103Balveen Kaur · Ohio State University · R01 · FY2014 · CA
BONE MARROW CELL ADHESION MOLECULES
$395,070Oklahoma Medical Research Foundation · R01 · FY2000 · AI
Bioorthogonal probe development for highly parallel in vivo imaging
$395,039Ralph Weissleder · Massachusetts General Hospital · R33 · FY2024 · CA
Project 2: Cellular topography and function of the breast cancer tissue microenvironment
$395,008Robert Michael Angelo · Stanford University · U54 · FY2022 · CA
A novel dual-carrier ultrasmall nanomedicine for the treatment of stroma-rich pancreatic cancer
$394,967Katherine Marie Eichinger · Duo Oncology Inc · R41 · FY2023 · CA
Integrative Somatic and Germline Computational Biology to Redefine Clinical Actionability in Solid Tumors
$394,959Eliezer M Van Allen · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Targeting the cytokine circuitry of KRAS-driven lung cancer
$394,956David A Barbie · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Integration of Genomic and Clinical Data to Enhance Subtyping of Colon Cancer
$394,948Frank A Sinicrope · Mayo Clinic Rochester · R01 · FY2019 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$394,916Song Li · University Of California Los Angeles · R01 · FY2023 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$394,916Song Li · University Of California Los Angeles · R01 · FY2022 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$394,879Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2022 · CA
Effects of Complement on the Tumor Microenvironment in Lung Cancer
$394,879Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2023 · CA